Caption: CEL-SCI's CEO Geert Kersten talks about the future of the company and it's lead investigational therapy Multikine. CEL-SCI is dedicated to research and development directed at improving the treatment of cancer and other diseases by utilizing the i
Credit: CEL-SCI Corporation